All Research Groups
Computer-aided drug design
Outi Salo-Ahen
osalo[at]abo.fi
Pharmaceutical Sciences and Structural Bioinformatics Laboratory,
Åbo Akademi University
Antibacterial, Bioinformatics, Biomolecular chemistry, Biopharmaceuticals, Cancer, Drug target, Hit to lead, Infection, Lead optimization, Medicinal chemistry, Molecular modelling, Natural Compounds, Natural products, Pharmacy, Preclinical development, Screening, Structural Biology
Molecular imaging of atherosclerosis and heart failure
Antti Saraste
antti.saraste[at]utu.fi
Heart Center and PET Center,
University of Turku
Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging
Synthetic Glycocluster Adjuvants
Johannes Savolainen
johsav[at]utu.fi
Department of Clinical Medicine,
University of Turku
Allergy, Asthma, Biomedicine, Biomolecular chemistry, Biotechnology, Cancer, Immunology, Inflammation, Melanoma, Natural Compounds, NMR, Organic Chemistry, Synthetic Biology, Synthetic chemistry, Target discovery
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Genetic predisposition to cancer
Johanna Schleutker
Johanna.Schleutker[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening
Radiochemistry for development of radiotracers for Positron Emission Tomography
Olof Solin
olof.solin[at]abo.fi, olof.solin[at]utu.fi
Turku PET Centre and Department of Chemistry,
University of Turku
Ageing-related diseases, Autoimmune diseases, Biomarker, Cancer, Data mining, Diabetes, Disease models, Drug delivery, Drug stability, Drug target, Formulation, Imaging, Imaging software, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular diagnostics, Molecular modelling, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Obesity, Organic compounds, Particle size analysis, PET, Physico-chemical properties, Receptor, Signaling, Synthetic chemistry, Target discovery, Zeta potential
